Cargando…

Immunomodulatory Protein Hydrolysates and Their Application

Immunomodulatory protein hydrolysate consumption may delay or prevent western immune-related diseases. In order to purposively develop protein hydrolysates with an optimal and reproducible immunomodulatory effect, knowledge is needed on which components in protein hydrolysates are responsible for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiewiet, Mensiena B. G., Faas, Marijke M., de Vos, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073538/
https://www.ncbi.nlm.nih.gov/pubmed/30011891
http://dx.doi.org/10.3390/nu10070904
_version_ 1783344213776138240
author Kiewiet, Mensiena B. G.
Faas, Marijke M.
de Vos, Paul
author_facet Kiewiet, Mensiena B. G.
Faas, Marijke M.
de Vos, Paul
author_sort Kiewiet, Mensiena B. G.
collection PubMed
description Immunomodulatory protein hydrolysate consumption may delay or prevent western immune-related diseases. In order to purposively develop protein hydrolysates with an optimal and reproducible immunomodulatory effect, knowledge is needed on which components in protein hydrolysates are responsible for the immune effects. Important advances have been made on this aspect. Also, knowledge on mechanisms underlying the immune modulating effects is indispensable. In this review, we discuss the most promising application possibilities for immunomodulatory protein hydrolysates. In order to do so, an overview is provided on reported in vivo immune effects of protein hydrolysates in both local intestinal and systemic organs, and the current insights in the underlying mechanisms of these effects. Furthermore, we discuss current knowledge and physicochemical approaches to identify the immune active protein sequence(s). We conclude that multiple hydrolysate compositions show specific immune effects. This knowledge can improve the efficacy of existing hydrolysate-containing products such as sports nutrition, clinical nutrition, and infant formula. We also provide arguments for why immunomodulatory protein hydrolysates could be applied to manage the immune response in the increasing number of individuals with a higher risk of immune dysfunction due to, for example, increasing age or stress.
format Online
Article
Text
id pubmed-6073538
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60735382018-08-13 Immunomodulatory Protein Hydrolysates and Their Application Kiewiet, Mensiena B. G. Faas, Marijke M. de Vos, Paul Nutrients Review Immunomodulatory protein hydrolysate consumption may delay or prevent western immune-related diseases. In order to purposively develop protein hydrolysates with an optimal and reproducible immunomodulatory effect, knowledge is needed on which components in protein hydrolysates are responsible for the immune effects. Important advances have been made on this aspect. Also, knowledge on mechanisms underlying the immune modulating effects is indispensable. In this review, we discuss the most promising application possibilities for immunomodulatory protein hydrolysates. In order to do so, an overview is provided on reported in vivo immune effects of protein hydrolysates in both local intestinal and systemic organs, and the current insights in the underlying mechanisms of these effects. Furthermore, we discuss current knowledge and physicochemical approaches to identify the immune active protein sequence(s). We conclude that multiple hydrolysate compositions show specific immune effects. This knowledge can improve the efficacy of existing hydrolysate-containing products such as sports nutrition, clinical nutrition, and infant formula. We also provide arguments for why immunomodulatory protein hydrolysates could be applied to manage the immune response in the increasing number of individuals with a higher risk of immune dysfunction due to, for example, increasing age or stress. MDPI 2018-07-14 /pmc/articles/PMC6073538/ /pubmed/30011891 http://dx.doi.org/10.3390/nu10070904 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kiewiet, Mensiena B. G.
Faas, Marijke M.
de Vos, Paul
Immunomodulatory Protein Hydrolysates and Their Application
title Immunomodulatory Protein Hydrolysates and Their Application
title_full Immunomodulatory Protein Hydrolysates and Their Application
title_fullStr Immunomodulatory Protein Hydrolysates and Their Application
title_full_unstemmed Immunomodulatory Protein Hydrolysates and Their Application
title_short Immunomodulatory Protein Hydrolysates and Their Application
title_sort immunomodulatory protein hydrolysates and their application
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073538/
https://www.ncbi.nlm.nih.gov/pubmed/30011891
http://dx.doi.org/10.3390/nu10070904
work_keys_str_mv AT kiewietmensienabg immunomodulatoryproteinhydrolysatesandtheirapplication
AT faasmarijkem immunomodulatoryproteinhydrolysatesandtheirapplication
AT devospaul immunomodulatoryproteinhydrolysatesandtheirapplication